Prognostic variables in node-negative and node-positive breast cancerGiampietro Gasparini Springer Science & Business Media, 6 dic 2012 - 428 páginas |
Índice
1 | |
17 | |
Steroid hormone receptors in breast cancer management | 35 |
Sphase fraction and breast cancer a decade of experience | 63 |
Cyclin D1 in breast cancer | 91 |
Cyclins and breast cancer | 107 |
new ligands and receptors and their role | 133 |
HER2neu as a predictive marker of response to breast cancer therapy | 155 |
Prognostic and predictive value of p53 and p21 in breast cancer | 169 |
The urokinase plasminogen activator system as a target for prognostic studies | 189 |
Metalloproteinases and tissue inhibitors of metalloproteinases | 203 |
Otras ediciones - Ver todo
Prognostic variables in node-negative and node-positive breast cancer Giampietro Gasparini Vista previa restringida - 1999 |
Prognostic variables in node-negative and node-positive breast cancer Giampietro Gasparini No hay ninguna vista previa disponible - 2012 |
Prognostic variables in node-negative and node-positive breast cancer Giampietro Gasparini No hay ninguna vista previa disponible - 2012 |
Términos y frases comunes
activity adjuvant therapy analysis angiogenesis antibody antigen assay associated axillary lymph node Biol biological breast cancer breast cancer cells breast cancer patients Breast Cancer Res breast carcinoma c-erbB2 Cancer Res Treat cell cycle cell lines chemotherapy Clin Oncol clinical correlation cutpoints cyclin D1 cyclin E detected disease disease-free survival endothelial estrogen receptor evaluated expression follow-up gene grade growth factor receptor hazard ratio HER2/neu histologic hormonal therapy human breast cancer IGF1R immunohistochemical inhibitor kinase laminin lesions levels ligand mammary matrix metalloproteinase metalloproteinase metastasis metastatic metastatic breast cancer microvessel count Natl Cancer Inst negative node-negative node-negative breast cancer node-positive Oncogene outcome overall survival overexpression Pathol ploidy predictive factors primary breast cancer prognostic factors prognostic markers prognostic significance prognostic value proliferation protein recurrence relapse response risk S-phase fraction studies surgery tamoxifen tissue treatment tumor cells tumor markers variables vascular